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Abstract Kv7.4 channels are key determinants of arterial
contractility and cochlear mechanosensation that, like all
Kv7 channels, have an obligatory requirement for phos-
phatidylinositol 4,5-bisphosphate (PIP2). βγ G proteins
(Gβγ) have been identified as novel positive regulators of
Kv7.4. The present study ascertained whether Gβγ increased
Kv7.4 open probability through an increased sensitivity to
PIP2. In HEK cells stably expressing Kv7.4, PIP2 or Gβγ
increased open probability in a concentration dependent man-
ner. Depleting PIP2 prevented any Gβγ-mediated stimulation
whilst an array of Gβγ inhibitors prohibited any PIP2-induced
current enhancement. A combination of PIP2 and Gβγ at sub-
efficacious concentrations increased channel open probability
considerably. The stimulatory effects of three Kv7.2-7.5 chan-
nel activators were also lost by PIP2 depletion or Gβγ inhib-
itors. This study alters substantially our understanding of the
fundamental processes that dictate Kv7.4 activity, revealing a
more complex and subtle paradigmwhere the reliance on local
phosphoinositide is dictated by interaction with Gβγ.
Keywords Potassium channel . KCNQ . PIP2 . G-protein
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Introduction
The Kv7 family of potassium channels (Kv7.1–Kv7.5) are
crucial determinants of cardiac, neuronal, cochlear and
vascular function [25, 26]. As such, defining the mechanisms
that control how Kv7 channel activity is regulated is crucial. It
is acknowledged that Kv7 channels have an obligatory re-
quirement for phosphatidylinositol 4,5-bisphosphate (PIP2)
[4, 12, 18], but we recently described how the Kv7.4 channel,
important for normal vascular function [6, 7, 15], requires G-
protein βγ subunits (Gβγ) for its voltage-dependent activity
[27]. Few ion channels are directly regulated by Gβγwith the
best studied being the G protein coupled inwardly rectifying
potassium (GIRK) channel that controls electrical excitability
in neurons and cardiac cells [9–11, 19]. This channel is com-
prised of Kir3.1–3.4 subunits and Gβγ enhance open proba-
bility by stabilizing the interaction of PIP2 [9, 13, 20]. We
speculated whether the stimulatory effects of Gβγ on Kv7.4
were due to an interaction with PIP2 analogous to GIRK chan-
nels. As such, Gβγ would be ineffective under conditions
where PIP2 levels were reduced. However, the study revealed
a level of regulation far more complex and provides the first
account of a synergistic regulation of Kv7.4 channels by Gβγ
and PIP2.
Methods
Cell cultureHuman embryonic kidney cells (HEK293) stably
transfected with Kv7.4 were maintained in modified Eagles’
medium containing 10% foetal calf serum, 1% penicillin/
streptomycin, 1% non-essential amino acids, 1% L-glutamine
and 1% sodium pyruvate. For experiments, cells were de-
tached by brief trypsin treatment. HEK Kv7.4 cells were plat-
ed on 13-mm coverslips in an external physiological salt so-
lution (PSS) containing (mM): KCl 6, NaCl 120, MgCl2 1.2,
CaCl2 2.5, D-glucose 12 and HEPES 10, pH was adjusted to
7.35 with NaOH. Cells were left on cover slips for 30 min at
room temperature and stored at 4 °C for up to 8 h.
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Whole-cell electrophysiology Macroscopic transmembrane
ionic currents of HEK293 Kv7.4 cells were recorded using
standard amphotericin B (300 μg/ml) perforated-patch tech-
niques in voltage-clamp mode. In some experiments, the rup-
tured whole-cell patch-clamp technique was used for intracel-
lular perfusion of active Gβγ subunits. Patch pipettes were
fire-polished and had a resistance of 4–8MΩwhen filled with
the pipette solution of the following composition (mM): KCl
126, MgCl2 1.2, HEPES 10 and EGTA 0.5, and pH was ad-
justed to 7.2 with KOH. Na2ATP (1 mM) was added to the
pipette solution for the ruptured whole-cell experiments. Cells
were held at −60 mVand current amplitude was monitored by
application of test pulse to +20 mV. To generate current-
voltage relationships, a voltage step protocol was used from
a holding potential of −60mV, testing a range of voltages from
−90 to +40 mV in 10-mV increments at 15-s intervals. Drugs
were applied in the external solution using a bath perfusion
system, except for Gβγ subunits which were included in the
pipette solution.
Single channel electrophysiology Single-channel activity of
Kv7.4 currents expressed in HEK293 cells was recorded in
voltage-clamp mode using inside-out patch configuration in
an external solution of the following composition (mM): KCl
165, HEPES 5 and EGTA 10, and pHwas adjusted to 7.2 with
NaOH. Patch pipettes were fire-polished and had a resistance
of around 20 MΩ when filled with PSS as a pipette solution.
Cells were voltage clamped at 0 mV. Cell-attached patch con-
figuration was used in some experiments. In this case, PSS
was used for both, pipette and bath solutions, and the cells
were recorded at −50mV, so the expected membrane potential
under the patch is around −6 mV (assuming resting membrane
potential of −56 mV [21]). All single-channel current records
were filtered at 0.1 kHz using a Frequency Devices 9002
digital filter with 8-pole low-pass Bessel filter and acquired
at 1 kHz (Axopatch 200B 4-pole low-pass Bessel filter).
Current amplitudes were calculated from idealized traces of
≥180 s in duration using 50% threshold method using pClamp
9.0 software. Events lasting less than 6.664 ms (2 × rise time
for a 100 Hz, −3 db, low-pass filter, [8]) were excluded from
the analysis to maximize the number of channel openings
reaching their full current amplitude. Channel activity was
expressed as NPo, which was calculated automatically and
reported by the pClamp 9.0 software under Bevent statistics^
after completion of the single-channel search procedure ap-
plied to the idealized traces ≥180 s in duration at each condi-
tion. All whole-cell and single-channel current recordings
were made using AXOpatch 200B amplifier (Axon
Instruments) at room temperature. Electrical signals were gen-
erated and digitized using a Digidata 1322A hosted by a PC
running pClamp 9.0 software (Molecular Devices). Drugs
were applied in the external solution using a push-pull system.
All electrophysiological data were analysed and plotted using
pClamp 9.0, MicroCal Origin 6.0 (MicroCal software,
Northampton, MA, USA) and GraphPad Prism (GraphPad
Software, Inc., La Jolla, CA, USA). PIP2 and βγ G proteins
were applied at a range of concentrations to inside-out excised
patches to determine the sensitivity of the Kv7.4 channel to
these modulators. However, it was not usually possible to hold
the patch long enough to do a full concentration-response and
saturating responses were not achieved. Data are therefore
accumulated from a number of patches and fitted by a sigmoidal
curve to give an approximate estimate of sensitivity. Values for
half maximal stimulation taken from these fits are quoted in the
text with the caveat that saturation of channel enhancement was
not seen with either molecule.
In-cell western blot In-cell western blot experiments were
performed as described elsewhere [5]. HEK293 cells stably
expressing Kv7.4 were grown in 96-well plates for 24 h and
incubated with different drugs as indicated. After treatment,
cells were fixed with 3% ice-cold paraformaldehyde for
10 min at room temperature (RT, 22–24 °C), washed with
PBS and blocked/permeabilised with PBS containing 5% bo-
vine serum albumin (BSA) and 0.2% Triton X-100 for 1 h at
RT. Cells were subsequently incubated for 14–16 h at 4 °C
with the following primary antibodies: mouse anti PIP2
(2C11, dil 1:200, Santa Cruz, Dallas, USA) and a loading
control rabbit anti-cytochrome c oxidase subunit IV (COX-
IV, dil 1:1000, Abcam, Cambridge, UK). After three washes
with PBS (10 min each), cells were incubated with anti-mouse
and anti-rabbit IgG conjugated to IRDye® 680RD and
IRDye® 800CW, respectively (dil 1:1000, Li-Cor,
Cambridge, UK), for 1 h at RT. All antibodies were diluted
in PBS containing 1% BSA and 0.04% Triton X-100. Cells
were then washed three times with PBS and imaged on the
Odyssey Infrared Imaging System (Li-Cor, Cambridge, UK)
and analysed with supplier’s software (Version 3.1).
Statistical analysisAll data are mean ± s.e.m. of n cells. One-
way ANOVA test followed by a Dunnett’s or Tukey’s multiple
comparisons test or Student’s t test were used to determine
statistical significance between groups, where * = P < 0.05,
** = P < 0.01, *** = P < 0.001 and **** = P < 0.0001.
ReagentsMany different pharmacological tools were used to
either alter PIP2 levels or impair βγ G protein interactions.
These are listed below with the supplier and mechanism of
action.
PIP2 depletion Wortmannin (Sigma Aldrich, Poole, UK), at
20 μM, is an inhibitor of myosin light chain kinase, phos-
phatidylinositol 3-kinase and phosphatidylinositol 4-kinase.
It depletes PIP2 levels by inhibiting synthesis from phospha-
tidyl inositol via the phosphatidylinositol 4-kinase [1, 21, 28].
PIP2 depletion was augmented by brief application of 1 μM
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trypsin that activates protease-activated receptors endogenous
to the HEK cell [30]. In addition, the phospholipid acceptorα-
Cyclodextrin and LY-294,002 hydrochloride, another inhibi-
tor of phosphatidylinositol kinase (both from Sigma), were
used for in-cell western blot studies.
Prevention of βγ G protein interactionWe used a range of
structurally different compounds that prevent βγ G proteins
interacting with effector proteins through different mecha-
nisms. Gβγ-target recognition is defined by a single
Bhotspot,^ which has distinct sub-surfaces for individual G
protein subunit interactions [3]. Gallein (Tocris, Avonmouth,
UK), M201 and M119K (provided by National Cancer
Institute Drug Development Programme, 3), all bind to the
hot spot at concentrations less than 1 μM but differentially
modulate Gβγ interactions with effectors [3]. Grk2i (Tocris,
Avonmouth, UK, 10 μM) is a peptide analogue of the G-
protein receptor kinase c-terminus [16] which competes with
effector proteins for βγ G protein binding. All reagents were
applied to the bathing solution at concentrations derived from
previous publications.
Additional materials G-protein βγ subunits from bovine
brain were purchased from Merck. PIP2 (D-myo-phos-
phatidylinositol 4,5-bisphosphate) was purchased from
Echelon. HEK293 cells stably expressing Kv7.4 were a gift
from the University of Copenhagen [2, 24]. Retigabine, S-1,
and NS15370 were synthesized by NeuroSearch A/S,
(Ballerup, Denmark). The pan-Kv7 blocker linopirdine was
purchased from Tocris (Avonmouth, UK).
Results
PIP2 depletion abolishes Kv7.4 currents and prevents
their activation by Gβγ
In HEK cells stably expressing Kv7.4, depolarisation evoked
characteristic time-dependent currents (Fig. 1) that were
abolished by treatment with the Kv7 blocker linopirdine
(10 μM) and were not apparent in untransfected HEK cells
[27]. Application of 20 μM wortmannin, to reduce PIP2
levels, gradually decreased Kv7.4 currents recorded in
perforated-patch whole-cell configuration (Fig. 1A). Further
inhibition of currents to a level identical to that recorded after
application of the Kv7 channel blocker linopirdine (10 μM)
was achieved by brief (≤30 s) application of 1 μM trypsin to
stimulate endogenous G-protein-coupled proteinase-activated
receptors (Fig. 1B). Wortmannin also reduced Kv7.4 channel
activity in cell-attached experiments (Fig. 1C). In-cell western
analysis showed that wortmannin alone and in the combina-
tion with trypsin application significantly decreased levels of
PIP2 in Kv7.4-transfected HEK cells (Fig. 1D). We then
investigated whether PIP2 depletion modified the stimulatory
response to enrichment of internal solutions with Gβγ. Like
our previous study [27], intracellular perfusion of active Gβγ
(250 ng/ml) increased current amplitude by ~70% within
5 min of rupture in control cells (Fig. 2A (a), B) but had
considerably less effect (~38% increase) in cells incubated
with 20 μM wortmannin (Fig. 2A (b), B). We then undertook
inside-out excised patch recording to investigate this effect
further. In HEK cells stably expressing Kv7.4 but not
untransfected cells, robust K+ channel activity was recorded
immediately upon patch excision that usually decayed within
1–2 min to a steady, lower level of activity. This is considered
to be due to the wash out of key intracellular mediators from
the membrane patch [4, 12, 18]. Bath application of Gβγ
(0.4–50 ng/ml) increased channel activity in a concentration-
dependent manner similar to previous work [27] with an esti-
mated value for half maximal stimulation of 8.1 ng/ml (n = 4–
7, Fig. 3A, B). However, bath application of Gβγ had no
effect (2.51 ± 0.05% increase only, n = 4) on the negligible
channel activity recorded in the continued presence of
wortmannin (Fig. 3C) whereas application of exogenous
PIP2 in the continued presence of wortmannin re-established
channel activity (Fig. 3D,n = 5). These data show that inhibi-
tion of PIP2 re-synthesis by wortmannin decreased PIP2,
reduced channel activity and prevented Gβγ-mediated
channel stimulation suggesting that Gβγ may act upstream
of PIP2.
Gβγ inhibition abolishes Kv7.4 currents and prevents
their activation by PIP2
Having established that PIP2 depletion impaired Gβγ-
mediated enhancement of Kv7.4 currents, we addressed
whether reduction of Gβγ activity limited the well-
established PIP2 enhancement of channels. Initially, we used
the in-cell western blot technique to ascertain whether Gβγ
inhibitors altered PIP2 levels. Figure 4A shows that neither
Grk2i, M201 nor M199K altered PIP2 levels whilst the well-
used small molecule Gβγ inhibitor gallein reduced PIP2 to
some extent. In a previous study, we showed that gallein,
Grk2i and an antibody raised against Gβ inhibited whole-
cell Kv7.4 currents markedly [27]. Application of two novel
and potent Gβγ inhibitors, M201 and M119K [3], also
inhibited whole-cell Kv7.4 currents significantly (Fig. 4B,
C). Figure 4C shows the accumulated data for all Gβγ
inhibitors on whole-cell Kv7.4 currents highlighting the
suppressive effect irrespective of mechanistic action. Having
established the effect of Gβγ inhibitors on whole-cell
currents, we then performed inside-out recordings to determine
how single-channel activity was affected. Figure 4D, and E
shows that M201 and Grk2i reduced the open probability of
Kv7.4 channels in excised patches to negligible levels similarly
to the action of gallein (Fig. 4F) [27].
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Having confirmed that inhibition of Gβγ inhibited Kv7.4
currents recorded at the whole-cell and single-channel level,
we used inside-out excised patches to ascertain if structurally
different Gβγ inhibitors altered PIP2-induced enhancement of
Kv7.4 activity. Under control conditions, application of PIP2
increased the apparent channel open probability (NPo) of the
Kv7.4 channel activity in a concentration-dependent manner
(Fig. 5A, B). This resulted in an estimated value for half-
maximal stimulation of 117 μM (n = 4–11) similar to previous
papers [4, 12, 18]. By comparison, no significant increase in
Fig. 1 PIP2 depletion reduces Kv7.4 currents.A Examples of whole cell
K+ currents from HEK293 Kv7.4 cells evoked by step depolarisation
from −60 mV to +20 mV in the absence (a) and presence of 20 μM
wortmannin (b). Currents were recorded every 15 s and wortmannin
applied after 60 s. Initial current trace is shown in black in both
subpanels. Subsequent traces after 5-, 10- and 20-min intervals are
shown in blue, green and red, correspondingly. Subpanel c shows the
mean amplitude of K+ current at +20 mV in the absence (black) and
presence of wortmannin (red). Each point is the mean ± s.e.m. of four
cells. B Representative traces of Kv7.4 currents evoked by steps from
−60 mV to a range of potential (−90 to +40 mV) in control (a) and
after depletion of PIP2 by the cells preincubation with wortmannin +
short (≤30 s) application of trypsin (b). The mean data are shown in
subpanel c with control (black, n = 22), wortmannin alone (green,
n = 34), wortmannin plus trypsin (red, n = 36) and linopirdine (purple,
n = 14).C Example of cell-attached patch recording fromHEK293Kv7.4
cell showing the effect of 20 μMwortmannin. Long-term trace is shown
in subpanel a. Representative expanded 1.75-s segments of channel
openings taken from subpanel a highlighting channel activity in the
absence, and the presence of wortmannin are shown in subpanels b and
c. Closed state and multiple open states are denoted by C and O1–O6. D
In-cell Western analysis showing that wortmannin, and other
known PIP2 inhibitors, decrease global PIP2 level in HEK293
Kv7.4 cells (n = 12–23)
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Kv7.4 channel activity was observed upon application of PIP2
(10–100 μM) in patches incubated in M201, gallein or Grk2i
(Fig. 5C–F). These data reveal that inhibition of Gβγ interac-
tion by structurally and mechanistically different agents not
only inhibits Kv7.4 basal activity but also prevented PIP2
stimulation of Kv7.4 (Fig. 5F).
PIP2 and Gβγ are synergistic regulators of Kv7.4
channels
Our data thus far suggest that rather than regulation of
Kv7.4 by PIP2 and Gβγ being a linear relationship, the
signal molecules combine to dictate channel function.
The next series of inside-out experiments aimed to de-
termine if a low sub-effective concentration of Gβγ
could enhance the sensitivity of the channel to exoge-
nous PIP2. Application of low concentrations of either
Gβγ (1 ng/ml) or PIP2 (1–3 μM) to inside-out patches
had a negligible effect on Kv7.4 channel activity
(Fig. 6A, C ). However, Fig. 6B–D shows that in com-
bination, a marked increase in channel activity was ob-
served and the presence of 1 ng/ml Gβγ increased the
sensitivity of the channel to PIP2. For instance, NPo
increased to 0.29 ± 0.07 (n = 6) when 3 μM PIP2
was applied in the presence of 1 ng/ml Gβγ, which
was significantly greater than NPo when 3 μM of
PIP2 alone was applied (0.077 ± 0.02, n = 8;
Fig. 6C). The stimulatory effect of Gβγ was not
apparent when 100 μM PIP2 was applied, suggesting
that the combinational effect had a functional ceiling
(Fig. 6D). Consequently, low concentrations of Gβγ
produced a leftward shift in the sensitivity of the Kv7.4
channel to PIP2 suggesting the two molecules acted
synergistically.
PIP2 depletion and reduced Gβγ activity affects
pharmacological modulation of Kv7.4
Application of three structurally different enhancers of
Kv7.2–7.5, S-1, retigabine and NS15370, produced a marked
increase in whole-cell currents in HEK cells stably expressing
Kv7.4 with currents at +20 mV increasing by approximately
40% (Fig. 7). In cells treated with wortmannin alone, some
enhancement with each activator was observed. However, in
cells bathed in either wortmannin plus trypsin or gallein alone,
the stimulatory effect of all three agents was abrogated.
Consequently, the ability of pharmacological agents to aug-
ment Kv7.4 was compromised by PIP2 depletion or reduced
βγ subunit activity.
Discussion
It is accepted dogma that Kv7 channels have an obligatory
reliance on PIP2 for effective function. We now reveal that
this positive regulation occurs synergistically with Gβγ, and
there is an obligatory reliance on both mediators to be present
for effective channel function. These findings change radically
our understanding on how Kv7.4 channels are regulated. If
other Kv7 channels are also affected by Gβγ in a similar
manner, the findings of the present study will have wide-
ranging implications as Kv7 channels regulate cellular physi-
ology in many cell types.We show by in-cell western blot that
treatment with the phosphatidylinositol-4-kinase inhibitor
wortmannin and stimulation of G-protein coupled receptors
with trypsin reduced global PIP2 and reduced Kv7.4 currents
to negligible levels (Fig. 1). More importantly, this treatment
abrogated the stimulatory effect of Gβγ on Kv7.4 channels
but did not impair the ability of exogenous 100 μM PIP2 to
Fig. 2 PIP2 depletion prevents activation of whole-cell Kv7.4
currents by Gβγ. A Representative whole-cell currents evoked
by depolarisation from −60 to +20 mV in Kv7.4 HEK293 cells
under control conditions (a) and after incubation in wortmannin
(20 μM, b). Right-hand panels show cells perfused internally with
Gβγ. B Mean data for the effect of intracellular perfused active
Gβγ on whole-cell currents recorded at +20 mV in the absence
and presence of 20 μM wortmannin (n = 5)
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enhance Kv7.4 channel activity in excised patches (Fig. 3).
This implied PIP2 sensitization underlies the positive effect of
Gβγ . However, t rea tment wi th s t ructura l ly and
mechanistically different inhibitors of Gβγ interactions
(gallein, M201, M199K and Grk2i) also decreased Kv7.4
channel activity (Figs. 3 and 4) to the same levels as treatment
Fig. 3 Gβγ enhancement of Kv7.4 channels in excised patches is
prevented by PIP2 depletion. A Representative inside-out patch
recording showing stimulatory action of Gβγ. Expanded 1.75 s
segments of channel openings in the absence (b) and presence of
2 ng/ml Gβγ (c) are taken from long-term recording (a). Closed state
and multiple open states are denoted by C and O1–O2. B Mean
concentration effect for Gβγ subunits (n = 4–7) fitted with a best-fit
sigmoidal to the available data. C Representative inside-out patch
recording from cell preincubated with wortmannin before (b) and after
(c) Gβγ application. Subpanels b and c are expanded 2.5-s segments of
channel openings taken from long-term recording (a). Closed state and
multiple open states are denoted by C and O1–O2. D, Representative
inside-out patch recording from cell preincubated with wortmannin
before (b) and after (c) PIP2 application. Subpanels b and c are
expanded 1.35-s segments of channel openings taken from long-term
recording (a). Closed state and open states are denoted by C and O1
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with wortmannin and trypsin, which mirrored the inhibition
produced by the Kv7 channel blocker linopirdine. Moreover,
all Gβγ inhibitors prevented any increase in channel activity
by exogenous PIP2 (100 μM) in excised patches (Fig. 5). It is
worth stressing that these inhibitors disable Gβγ interactions
with target proteins through different binding domains and
mechanisms [3], consistent with Gβγ having differential pro-
tein effector sites but all suppressed PIP2-induced enhance-
ment of Kv7.4 open probability. These findings suggested that
PIP2 was not simply an upstream channel regulator. In fact,
Fig. 4 Gβγ inhibition abolishes
Kv7.4 currents without change in
PIP2 levels. A In-cell Western
analysis showing influence of
Gβγ inhibitors on PIP2 level in
HEK293 Kv7.4 cells (n = 11–22).
BMean I-V relationships of
HEK293 Kv7.4 currents evoked
from holding potential −60 mV
before and after application of
M201 (50 μM). CMean data for
the effect for mechanistically
different inhibitors of Gβγ on
whole-cell K+ currents recorded
at +20 mV (n = 5–7). D
Representative inside-out patch
recording showing inhibitory
action of 50 μMM201 on single
channel activity. Subpanels b and
c are representative 1.5-s
segments of channel openings
before and after drug application
taken from long-term recording
(a). Closed and open states are
denoted by C and O1. E
Representative inside-out patch
recording showing inhibitory
action of 10 μM Grk2i on single
channel activity. Subpanels b and
c are expanded 2.8-s segments of
channel openings before and after
drug application taken from
long-term recording (a). Closed
state and multiple open states are
denoted by C and O1–O3. F
Mean apparent open probability
for Kv7.4 channels in control
conditions (green column, n = 14)
and after application of three
different Gβγ inhibitors, M201,
gallein and Grk2i (n = 4–6)
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these findings reveal that inherent Kv7.4 channel activity is
dictated by a coordinated interaction with PIP2 and Gβγ.
Removal of either regulatory arm leads to progressive run
down of channel activity and refractoriness to stimulation by
the opposing molecule. The synergistic effect of PIP2 and
Gβγ was substantiated by the observation that a
sub-efficacious dose of Gβγ (1 ng/ml) potentiated the
response to a low concentration of PIP2 (1–10 μM), but not
Fig. 5 Gβγ inhibition prevents
activation of Kv7.4 channels by
exogenous PIP2. A
Representative inside-out patch
recording showing stimulatory
action of PIP2. Subpanels b and c
are 1.75-s segments of channel
openings in the absence (b) and
presence of PIP2 (100 μM, c)
taken from long-term recording
(a). Closed state and multiple
open states are denoted by C and
O1–O3. BMean concentration-
effect for PIP2 (n = 4–11). C
Representative inside-out patch
recording showing that in the
continued presence of
50 μMM201 (continuation of
recording from patch shown in
Fig. 4D), 100 μM PIP2 applied to
the patch failed to activate the
channels. Subpanel b is a 1.5-s
segment of channel openings
taken from long-term recording
(a). Closed state and multiple
open states are denoted by C and
O1. D Representative inside-out
patch recording showing that in
the continued presence of 100 μM
gallein, 100 μM PIP2 applied to
the patch failed to activate the
channels. Subpanel b is a 2.5-s
segment of channel openings
taken from long-term recording
(a). E Representative inside-out
patch recording showing that in
the continued presence of 100 μM
Grk2i (continuation of recording
from patch shown in Fig. 4E),
100 μM PIP2 applied to the patch
produced only negligible
activation of the channels.
Subpanel b is a 2.8-s segment of
channel openings taken from
long-term recording (a). F
Normalized increase in NPo
produced by 100 μM PIP2
applied to inside-out patches in
the absence and presence of
different Gβγ inhibitors (n = 4–6)
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a saturating dose of PIP2 (100 μM), resulting in a pro-
nounced leftward shirt in the response to exogenous PIP2
(Fig. 6).
In addition to the control of Kv7.4 activity at rest, we also
show that compounds that activate Kv7.2–7.5 through a com-
mon molecular mechanism [14, 17, 22, 33] also required PIP2
and Gβγ binding to be effective. These findings corroborate
previous work that showed retigabine-induced stimulation of
Kv7.2/7.3, which comprise the neuronal M-channel, was neg-
ligible after PIP2 depletion [35]. Interestingly, the pharmaco-
logical dependence on PIP2 was localized to an interaction site
more proximal than the well-established C-terminus site nec-
essary for channel activity [35]. It is possible that the syner-
gistic effect of Gβγ is due to alterations of endogenous levels
of PIP2 as Gβγ do activate phospholipase Cβ and
phosphoinositide-3-kinase [23]. However, these enzymes
would reduce rather than enhance PIP2 levels. Moreover, the
Gβγ inhibitors M201, M199K and Grk2i had no discernible
effect on PIP2 levels whereas gallein decreased global PIP2.
This effect of gallein has not been reported previously and
there is no reason for the effect. The fact that other Gβγ
inhibitors did not alter global PIP2 levels suggests it is a quirk
of the molecule rather than of Gβγ inhibition.
The dual regulation of Kv7.4 by PIP2 and Gβγ identified
in the present study bears a considerable similarity to GIRK
channels, which have a co-dependence on Gβγ and PIP2 [10,
20]. Early studies proposed that Gβγ stabilized the PIP2 in-
teraction with Kir3.1/Kir3.4 [13, 29]. Crystallographic studies
revealed that full GIRK activation was reliant upon PIP2
interacting with an internal gate independent of the G-gate
where Gβγ binds, and no channel openings occurred if either
gate was unoccupied [31, 32]. Currently, the same level of
Fig. 6 PIP2 and Gβγ are synergistic regulators of Kv7.4 channels. A
Representative inside-out patch recording showing lack of effect of
1 ng/ml Gβγ on channel activity. Subpanel b is an expanded 1.65-s
segment of channel openings taken from long-term recording (a).
Closed and open states are denoted by C and O1. B Application of
3 μMPIP2 in the presence of 1 ng/ml Gβγ (patch from (A)) significantly
increased channel activity. Subpanel b is an expanded 1.65-s segment of
channel openings taken from long-term recording (a). Closed state and
multiple open states are denoted by C andO1–O3.CMean apparent open
probability for Kv7.4 in control conditions (n = 16), after application of
low concentrations of Gβγ (n = 8) and PIP2 alone (n = 8) and in
combination (n = 6). D Mean apparent open probability for Kv7.4
activated by PIP2 alone (n = 4–11, dark blue columns) and in the presence
of 1 ng/ml Gβγ (cyan columns, n = 4–10)
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molecular insight does not exist for Kv7.4. PIP2-binding do-
mains have been identified in other Kv7 family members, but
this information is lacking for Kv7.4. In addition, there is no
information on binding sites for Gβγ. In GIRK channels,
approximately 12 sites across the protein have been identified
as important for Gβγ binding that combine to accommodate 4
Gβγ molecules in the functional tetramer [9, 11, 34].
Moreover, distinct high- and low-affinity sites exist in
GIRKs that determine basal activation and receptor-
mediated activation, respectively [11]. These aspects of
molecular recognition need to be determined for Kv7.4.
A criticism that could be levelled at this study is it relies
solely on pharmacological agents for the conclusion.
However, we use blockers that are not only structurally differ-
ent but which work through varied mechanisms. As
wortmannin and various inhibitors of Gβγ reduced Kv7.4
channel activity to negligible levels, there must be sufficient
PIP2 and Gβγ in the channel locality to sustain channel activ-
ity under excised patch conditions. It is generally assumed that
PIP2 levels remain consistent in a normal healthy cell and are
replenished rapidly upon hydrolysis. Our data show that
Kv7.4 activity is attenuated by Gβγ inhibitors, implying that
there is a persistent influence of Gβγ maintaining channel
activity. Again, there is a parallel with GIRK channels that
have a basal level of activity due to constitutive binding of
Gβγ [11]. The free Gβγ maintaining Kv7.4 activity may be
the product of binding of Gα to the channel protein and the
associated tethering of Gβγ as shown for Kir3.1 [11], local-
ized G-protein coupled receptor activity or a labile free pool of
Gβγ. Irrespective of these unknowns, we have identified that
Kv7.4 activity is crucially dependent on a synergistic interplay
between PIP2 and Gβγ. Kv7 channels are well known to have
an obligatory requirement for PIP2 but this study reveals a
more complex and subtle paradigmwhere the reliance on local
phosphoinositide is dictated by an involvement of Gβγ.
Whilst the present study focuses on heterologous expression,
the findings have physiological implications because Kv7
channel isoforms have a key role in many cell types. Kv7.1
comprises the late repolarising component of the cardiac ac-
tion potential, Kv7.2/7.3 and Kv7.5/7.3 heteromers constitute
the M-channel in neurones and Kv7.4 has a role in cochlear as
well as arterial reactivity. Dysregulation of these channels im-
pacts considerably on cellular activity in each cell type under
consideration. Defining the mechanisms that regulate Kv7
channels is therefore paramount for understanding physiolog-
ical and pathophysiological processes. We have already
established that βγ G proteins modulate endogenous Kv7
channels in arterial smooth muscle cells consistent with their
effects on heterologously expressed Kv7.4 [24], and it is likely
that similar effects occur on native Kv7 channels in other
systems. If this is the case, then revelation of the present study
will have profound resonance for cellular regulation.
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